Discovering and developing transformational precision therapies

Extending the definition of what constitutes human biology

We go beyond human biology when searching for drug targets and therapies

About Company

Proprietary platform

We've built a suite of proprietary tools and capabilities into our platform. These tools have allowed for increased efficiencies, mass data integration, machine learning & identification at the strain level.

Each of our the tools is proprietary to Second Genome. How these tools work together to discover therapeutics and biomarkers are also proprietary and unique to the Second Genome platform.

Learn more

Advancing pipeline


program icon
  • Indication: Inflammatory bowel disorders
  • image description Peptide: SG-2-0776
  • image description Target: PAI-1 / PAI-2
  • IP filed


program icon
  • Indication: solid tumors
  • image description Peptide: SG-3-06686
  • image description Target: CXCR3
  • IP filed


8 additional in early discovery programs

We have two advanced programs in IND-enabling studies. An additional 8 programs are in early discovery.

Learn more